Baxion
Screening
Tags
Alerts
Theme
Indaptus Therapeutics, Inc.
INDP
·
NASDAQ
·
$1.11
Share Price as of 11/2
·
$2M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/13/26
10-Q
Q1 ended 03/31/26
05/15/26
10-K
FY 2025
03/17/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/13/25
Disclosures
Filter
8-K
Current report
10/20/26
8-K
Current report
09/30/26
8-K
Entry into Material Agreement; Unregistered Sales of Equity
09/10/26
8-K/A
Current report (amended)
09/08/26
8-K
Change in Directors or Officers
09/04/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
10/05/26
424B5
Prospectus supplement
09/04/26
424B5
Prospectus supplement
08/31/26
424B3
Prospectus
08/26/26
S-3
Shelf registration
08/17/26
Proxies
Filter
DEF 14A
Definitive proxy
07/16/26
PRE 14A
Preliminary proxy
06/22/26
DEFA14A
Additional proxy materials
02/12/26
DEF 14A
Definitive proxy
01/21/26
PRE 14A
Preliminary proxy
01/08/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
10/22/26
SC 13D/A
Beneficial ownership (amended)
10/22/26
SC 13D/A
Beneficial ownership (amended)
10/22/26
SC 13D/A
Beneficial ownership (amended)
10/21/26
SC 13D/A
Beneficial ownership (amended)
06/26/26
Other
Filter
EFFECT
Request for effectiveness
08/25/26
EFFECT
Request for effectiveness
07/17/26
EFFECT
Request for effectiveness
08/20/25
EFFECT
Request for effectiveness
08/20/25
CORRESP
Correspondence with the SEC
08/19/25
Latest Filings
Filter
8-K
Current report
10/20/26
S-8
Registration of securities for employees
10/05/26
8-K
Current report
09/30/26
8-K
Entry into Material Agreement; Unregistered Sales of Equity
09/10/26
8-K/A
Current report (amended)
09/08/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
10/22/26
SC 13D/A
Beneficial ownership (amended)
10/22/26
SC 13D/A
Beneficial ownership (amended)
10/22/26
SC 13D/A
Beneficial ownership (amended)
10/21/26
SC 13D/A
Beneficial ownership (amended)
06/26/26